Dozens of convicts and ex-convicts were granted pardon by President Bola Tinubu on Thursday, following the approval ...

Marketing and manufacturing practices for compounded GLP-1RA drugs have come under FDA scrutiny, prompting policy changes.

In this week’s edition of InnovationRx, we look at the Haitian immigrant who built a $6 billion company treating brain ...

Pharmaceutical stocks are having a moment. The S&P 500 Pharmaceuticals Index recently rose 11% during five trading days, its ...

As the Trump administration makes pacts with pharmaceutical manufacturers, consumers need more transparency about who is ...

Trump’s focus on lowering drug prices targets a critical issue for Americans. But without far greater transparency, it’s ...

What impact will TrumpRx and other DTC programs have on drug availability? Jesse Mendelsohn: To be clear, anything that expands access to pharmaceutical ...

It’s hard to find things that Donald Trump and Bernie Sanders agree on, but one point of consensus is that pharmaceutical ...

President Tinubu’s decision to pardon nearly 50 drug offenders has sparked fierce criticism from opposition figures and ...

The EU’s new pharmaceutical legislation is one of the most important opportunities ahead, says EMA head Emer Cooke ...

As the new United States Attorney for the Northern District of West Virginia, Matthew Harvey knows that, among his primary ...

President Tinubu granted clemency to most of them based on the reports that the convicts had shown remorse and good conduct.